TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Executive Medicine AB
Closing information (x1000 SEK)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
4,952
|
4,810 | |
Financial expenses |
10
|
15 | |
Earnings before taxes |
51
|
453 | |
EBITDA |
61
|
469 | |
Total assets |
707
|
593 | |
Current assets |
682
|
568 | |
Current liabilities |
575
|
464 | |
Equity capital |
132
|
129 | |
- share capital |
50
![]() |
50 | |
Employees (average) |
6
|
7
|
5 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
18.7%
|
21.8% | |
Turnover per employee |
707
|
962 | |
Profit as a percentage of turnover |
1.0%
|
9.4% | |
Return on assets (ROA) |
8.6%
|
78.9% | |
Current ratio |
118.6%
|
122.4% | |
Return on equity (ROE) |
38.6%
|
351.2% | |
Change turnover |
142
|
1,779 | |
Change turnover % |
-21%
|
3%
|
59% |
Chg. No. of employees |
-1
|
2
![]() |
2 |
Chg. No. of employees % |
-14%
|
40%
|
67% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.